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Abstract
Background: Perilipin1, a lipid droplet associated protein has an important role in the regulation of lipolysis and
lipid storage in adipocytes. Perilipin1 is also expressed in foam cells of atheroma plaques and could therefore play
a role in the accumulation of lipids in arterial wall and in the development of atherosclerosis. The aim of the study
was to investigate this possible role of perilipin1 in atherogenesis.
Methods: Mice deficient in perilipin1 (Plin1-/-) were crossed with Ldlr-/- mice. Ldlr-/- and Plin1-/- Ldlr-/- mice
received an atherogenic diet during 10 or 20 weeks. Blood pressure and plasma lipids concentrations were
measured. Aortas were collected at the end of the atherogenic diet periods for quantification of atheroma lesions
(en face method), histological and immunohistological studies
Results: Ldlr-/- and Plin1-/- Ldlr-/- mice had comparable blood pressure and plasma lipids levels. Plin1-/- Ldlr-/- mice
had a lower body weight and decreased adiposity. The atherosclerotic lesion area in Plin1-/-Ldlr-/- mice was
moderately increased after 10 weeks of atherogenic diet (ns) and significantly higher after 20 weeks (p < 0.01).
Histology of atheroma plaques was comparable with no sign of increased inflammation in Plin1-/- Ldlr-/- mice.
Conclusion: Perilipin1 ablation in mice results in increased atherosclerosis independently of modifications of risk
factors such as raised blood pressure or plasma lipids levels. These data strongly support an atheroprotective role
for perilipin1.
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Introduction
A hallmark of atherosclerosis is the accumulation of free
(FC) and esterified (EC) cholesterol in macrophages and
smooth muscular cells transforming them in foam cells
[1]. Such accumulation depends on the balance between
the uptake of cholesterol-rich lipoprotein through scaven-
ger receptors [2] and the efflux of free cholesterol con-
troled by the transporters ABCA1 and ABCG1 [3] and to
a lesser extent by SR-B1 (or CLA-1) [4,5]. This accumula-
tion depends also on the intra-cellular metabolism of cho-
lesterol, particularly the balance between its free and
esterified forms. CE taken up by cells is hydrolyzed in lyso-
somes to FC that is then directed to various cell mem-
branes by the protein NPC1 [6]. Excessive accumulation
of FC has toxic effects on cells [7] and FC must be either
by removed through efflux to extra-cellular acceptors or
esterified. CE is then stored in lipid droplets and can be
removed from cells only after hydrolysis to FC by a choles-
terol ester hydrolase, whose nature is still debated [8-10].
Storage of lipids droplets in cells accumulating triacyl-
glycerols (adipocytes, hepatocytes) or EC (steroidogenic
cells) is also dependent in part of specific proteins sur-
rounding these droplets and belonging to the PERILIPIN
family (previously named PAT family) [11], particularly
perilipin1 (previously perilipin) and perilipin2 (previously
adipophilin or ADRP). Perilipin2 is present in all cells
storing lipids [12]. Its expression is increased during
incubation of macrophages with oxidized LDL [13,14]. It
is expressed in foam cells of atherosclerotic plaques [14].
Its overexpression in THP-1 macrophages enhances lipid
accumulation [15] whereas its invalidation protects
against atherosclerosis [16]. Therefore perilipin2 is clearly
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any medium, provided the original work is properly cited.involved in atheroma. Perilipin1 has at least three differ-
ent forms, perilipin1 A, B and C, resulting from alterna-
tive splicing of a common premessenger RNA [17].
Perilipin1 A and B are present in adipocytes, the A form
being largely predominant. Perilipin1 C is found in ster-
oidogenic cells. In adipocytes, perilipin1 opposes in the
basal state hydrolysis of triacylglycerols. b-adrenergic
agents phosphorylate perilipins1 on specific serine sites
and phosphorylated perilipins 1 allow phosphorylated
HSL to hydrolyze TG. Perilipins1 are thus implicated in
the regulation of basal and stimulated lipolysis. Perilipin1
A is expressed in macrophages [18-21] and vascular
smooth muscular cells [18], in arterial wall [18] and is
overexpressed in atheroma plaques [18,22], particularly
unstable plaques [22]. Perilipin1 could therefore be impli-
cated in the development of atherosclerosis by controling
the hydrolysis of stored EC. The overexpression of perili-
pin1 in atheroma plaque could favour the accumulation
of cholesterol and promote the development of atheroma.
However, perilipin1 could also shift the balance between
FC and EC toward EC and help to prevent excessive
accumulation of FC. Since excess FC is toxic for cells and
plays a role in the evolution of plaques toward instability
[7,23], perilipin1 could have on the contrary a protective
role. In a first step to clarify this issue and to determine
the role, if any, of perilipin1 in atheroma, we investigated
the effect of perilipin1 invalidation on the development
of atheroma in an experimental model, the Ldlr
-/-
mouse.
Methods
Plin1
-/- mice were a gift from I Tabas (Columbia Univer-
sity, NY, USA). These mice are from the strain generated
and described by Martinez-Botas et al [24] and are on a
C57BL/6 background. Ldlr
-/- mice (C57BL/6 back-
ground) were from the Jackson Laboratory (Bar Harbor,
ME, USA). Plin1
-/- and Ldlr
-/- mice were crossed to
obtain Plin
+/-Ldlr
+/- mice, which were intercrossed to
obtain Ldlr
-/- and Plin1
-/- Ldlr
-/- mice. All mice were
housed in an animal facility with controlled temperature
(21-23°C) and lighting (light on 07:00, light off 19:00) and
had free access to food and water. Male mice were used
for the experiments. These mice received, starting at 8
weeks of age, an atherogenic diet (38.4% fat, 0.15% cho-
lesterol, U8958 version 52 from SAFE, Augy, France) and
were investigated after 10 (8 Ldlr
-/-,1 3Plin1
-/- Ldlr
-/-
mice) or 20 weeks (13 Ldlr
-/-,3 0Plin1
-/- Ldlr
-/- mice) of
atherogenic diet. This study was approved by the Ethical
Committee of the University Cl Bernard of Lyon.
Blood pressure and heart rate were measured in 20
weeks old mice (8 Ldlr
-/-and 16 Plin1
-/- Ldlr
-/- mice) by
the tail-cuff method (Visitech 2000 series II) after acclima-
tion to restrain and tail-cuff inflation. For quantification of
atheroma mice were anaesthetized with pentobarbital.
Blood was collected from inferior vena cava and plasma
separated by centrifugation for enzymatic determination
(Biomerieux, Lyon, France) of total cholesterol and of tria-
cylglycerols concentrations. Aortas were dissected from
aortic root to iliac bifurcation, carefully cleaned form peri-
arterial adipose tissue, pinned on silicon dishes and stained
for lipid deposits with Red Sudan IV (en face method). Red
Sudan IV positive areas were quantified using Image J soft-
ware and expressed as the percentage of total aorta area.
For histological studies some aortas of 20 weeks athero-
genic diet fed mice were rinced with PBS and fixed in
phosphate buffered formalin, carefully dissected, dehy-
drated and embedded in paraffin before sectioning. Hae-
matoxylin-eosin and Verhoeff (elastic fibres) stainings
were performed as well as immunocytology for macro-
phages (anti-Mac3 antibodies), lymphocytes (anti-CD3
antibodies) and smooth muscular cells (anti a-SMA anti-
bodies) [25]. For measurements of mRNA concentrations
aortas of 20 weeks atherogenic diet fed mice (5 Ldlr
-/-and
5 Plin1
-/- Ldlr
-/-) were removed, flushed with cold isotonic
saline, carefully cleaned of perivascular adipose tissue and
flash frozen in liquid nitrogen before storage at -80°C until
analysis. Total RNAs were purified using TRIZOL
R proto-
col (Invitrogen, Cergy-Pontoise, France) with the addition
of a DNase treatment. Concentrations, intergrity and pur-
ity were verified. For measurements of individual mRNA
levels (IL-6, IL1-b,T N F a,M C P - 1 ,S R - A ,A B C A 1 ,
ABCG1), total RNA was reverse transcripted using Super-
script II (Invitrogen) and random hexamers. Real time
PCR was performed in a MyIQ thermal cycler (Biorad,
Marnes La Coquette, France) using iQ SYBR green Super-
mix (Biorad). Samples were run along with dilutions of
known amounts of target sequence for quantification of
initial cDNA copies. Results were calculated as the target
over 18S RNA concentration ratio (ng/μg). Primer
sequences are shown in table 1.
Results are shown as individual values or as means ±
sem. Comparisons between groups were performed by
Student t test for non paired values or by Mann-
Table 1 Primers used for determinations of mRNAs
concentration
Forward primer Reverse primer
IL-6 GCTGGAGTCACAGAAGG TAGATGAGCCGTTTGGA
IL-1b AGTCCCAGTGTTCYYGG GCTGGACTGTTTCTAATGC
TNFa GCCACCACGCTCTTCTG GCTCACTGTTCGGACATCG
MCP-1 ACAACCACCTCAAGCAC CAATACCATAAGGGAAAGT
ABCA1 TCCTGTGCCATTTATTC GTTACTTAGTGGTCCTTCTT
ABCG1 ATGAATCAGCGAATGTTG GTTCTAATGGGTGCCTCT
SR-A CATCACCAACGACCTCAG TGTCCAGTAAGCCCTCT
18S TGAGGCCATGATTAAGAGGG AGTCGGCATCGTTTATGGTC
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P < 0.05 was considered as indicating a significant
difference.
Results
Plasma cholesterol levels were high in both Plin1
-/- Ldlr
-/-
and Ldlr
-/- mice but did not differ between the two groups
of mice (table 2). Plasma triacylglycerols levels were com-
parable. Systolic blood pressure (111.5 ± 3.1 vs 116.5 ±
6.6 mmHg in Ldlr
-/- mice) and heart rate (547 ± 25 vs
515 ± 23 b/min) were also comparable. Plin1
-/- Ldlr
-/- had
a slightly lower body weight (10 weeks: 25.2 ± 0.4 vs
27.8 ± 0.7g p < 0.01; 20 weeks: 27.6 ± 0.5 vs 30.0 ± 0.9g
p < 0.05) and as expected [24] an evident decrease at
examination of fat pads volume. Despite these comparable
blood pressure and plasma lipids levels and decreased fat
mass, Plin1
-/- Ldlr
-/- mice had after 10 weeks of athero-
genic diet a trend for increase in atherosclerosis (figure 1)
as quantified by the en face method. This increase was sig-
nificant (+55%, p < 0.01) at 20 weeks. Figure 2 shows a
representative sample of the extent of lesion in aortas
from Plin1
-/- Ldlr
-/- and Ldlr
-/- mice. Histological exami-
nation of plaques performed on aortas from mice fed
since 20 weeks the atherogenic diet showed no differences
in structure (elastic lamellae, fibrosis, cellularity) between
Plin1
-/- Ldlr
-/- and Ldlr
-/- mice (figure 3). The abundance
of lymphocytes and macrophages estimated by immunocy-
tology (figure 4) was comparable and there was no evi-
dence of increased inflammation in plaques of Plin1
-/-
Ldlr
-/- mice. In addition we found no increase in the
mRNA levels of MCP-1, IL-6 or IL1-b (data not shown)
and only a non significant trend for higher values of
TNFa mRNA (1.72 ± 0.37 10
-4 vs 1.13 ± 0.26 10
-5 ng/μg
18S RNA p = 0.10) in aortas from Plin1
-/- Ldlr
-/- mice.
The expression of SR-A, implicated in the uptake of modi-
fied lipoproteins, and of ABCA1 and ABCG1, controlling
the efflux of cholesterol, were increased in aortas of
Plin1
-/- Ldlr
-/- mice (respectively 3.59 ± 1.06 10
-1 vs 4.81 ±
1.09 10
-2, 5.85 ± 1.53 10
-3 vs 2.94 ± 1.03 10
-4 and 7.17 ±
2.95 10
-4 vs 1.44 ± 0.45 10
-4 ng/μg 18S RNA, p < 0.05
for all).
Discussion
The present results support an atheroprotective role of
perilipin1 since the extent of atheroma lesions was
increased in Ldlr
-/- mice with perilipin1 ablation. The
overall histological appearance of the plaques was
unchanged and we observed no increase in macrophages
or lymphocytes infiltration, nor any significant increase
in the mRNA concentrations of pro-inflammatory cyto-
kines and chemokines. Therefore inflammation does not
Table 2 Plasma lipid concentrations in mice after 10 or
20 weeks of atherogenic diet
Total cholesterol g/l Triacylglycerols g/l
Ldlr
-/- Ldlr
-/- Plin1
-/- Ldlr
-/- Ldlr
-/- Plin1
-/-
10 weeks 9.99 ± 0.71 10.07 ± 0.96 1.32 ± 0.20 1.34 ± 0.55
20 weeks 8.56 ± 1.39 9.79 ± 0.32 0.75 ± 0.34 1.02 ± 0.38
Results are shown as mean and sem.
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Figure 1 Quantification of atheroma in aortas of Ldlr
-/-and
Ldlr
-/- Plin1
-/-mice after 10 and 20 weeks of atherogenic diet.
Quantification was performed with staining of lipid deposits by Red
Sudan IV (en face method). Results are shown as individual values
and means. ** p < 0.01 vs Ldlr
-/- mice.
     A             B 
Figure 2 Representative example of atheroma lesions in aorta
isolated from Ldlr
-/- Plin1
-/-(right aorta, B) and Ldlr
-/-(left aorta,
A) mice. Staining with Red Sudan IV.
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result mainly form an increase in lipid deposits. Such an
increase is demonstrated by the examination of aortas
by the en face method since Red Sudan IV stains lipid
deposits. An increased expression of SR-A could contri-
bute to this increase in lipid deposits. The increase in
ABCA1 and ABCG1 expression would on the contrary
favour cholesterol efflux and could be an adaptative
response to the increased accumulation of intra-cellular
cholesterol. Perilipin1 can be found in macrophages and
vascular smooth muscular cells and is present within
atheroma plaques in foam cells originating from both
cell types [18-22]. We used mice with a global invalida-
tion of perilipin1 and cannot delineate the respective
roles of macrophages and smooth muscular cells perili-
pin1 in the evolution of atheroma. This will need inves-
tigating mice with tissue specific invalidation. We
cannot exclude an indirect effect on atheroma of perili-
pin1 ablation outside of the vasculature, i.e. in adipose
tissue. However, blood pressure and plasma lipid levels
were unaffected while body weight and fat mass (as
appreciated by fat pads volume) were reduced by perili-
pin1 ablation. Therefore we can exclude a role for three
major risk factors for atheroma (hypertension, higher
plasma lipid levels, obesity) in the enhanced athero-
sclerosis we observed. Physical activity was also
unchanged (data not shown) in agreement with previous
reports [26]. Perilipin1 invalidation induces however
some peripheral insulin-resistance, despite the reduced
a d i p o s i t y[ 2 7 ] .W ec a n n o te x c l u d ear o l ef o rs u c hi n s u -
lin-resistance.
Conclusion
In conclusion we found a protective role of perilipin1
against atherosclerosis. Evaluation of the respective roles
of perilipin1 in macrophages and in smooth muscular
cells and elucidation of the precise mechanisms impli-
cated will require further studies.
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Figure 3 Atherosclerosis in Ldlr-/- (panels A and C) and Plin-/- Ldlr-/- (panels B and D) mice. Haematoxylin-eosin (panels A and B) and
Verhoeff (panels C and D) stainings were performed on paraffin sections of aortas. Representative sections of atheroma plaques are shown.
Magnification: ×10 (Ve rhoeff) ×20 (Haematoxylin-eosin). Scale: 100 μm.
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